“Irinotecan (CamptoR) Pharmacokinetics and Metabolism in Patients with Elevated Serum Bilirubin Levels” (2016) Journal of Cancer Research Updates, 5(2), pp.  67–72. doi:10.6000/1929-2279.2016.05.02.4.